Yifan Pharmaceutical Hits Day Low at CNY 13.28 Amid Price Pressure

Yifan Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 4.79% as it reached an intraday low of CNY 13.28. This performance stands in contrast to the China Shanghai Composite, which fell by 1.24% on the same day. Over the past week, Yifan's stock has decreased by 1.33%, while the broader index has seen a more significant decline of 3.38%. In terms of longer-term performance, Yifan has shown a 10.73% increase over the past month, outpacing the Shanghai Composite's decline of 3.06%. However, the company's one-year performance of 15.34% is slightly below the index's return of 16.08%. Year-to-date, Yifan has gained 11.29%, contrasting with the Shanghai Composite's slight loss of 0.3%. Despite these fluctuations, Yifan's financial metrics indicate challenges, including a low Return on Capital Employed (ROCE) of 2.72% and a Debt to Equity ratio that suggests a high level of leverage. The company's long-term growth has also been hindered, with net sales declining at an annual rate of 1.21% over the past five years.